Recursion Pharmaceuticals Inc.
Chief Business Officer Shaf Virani's takeaways from BIO 2022
05/23/2022 | Press release | Distributed by Public on 05/23/2022 06:11
Please select the service you want to use:
Smartlinks | Seagen Inc. | News | Health | Science | Research | Local News | Company News | Top Company News | Shareholders | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Lifestyle and Leisure | Leisure | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago | Bolsa Institucional de Valores (BIVA)
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact